The patient safety story. by Elwyn, G. & Corrigan, J.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/48521
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
only if symptoms persist, are other strategies safer?
These might include policies to always or never
prescribe antibiotics in upper respiratory infection, to
ask patients to return to the doctor for further
assessment if they feel worse, and to prescribe only for
patients at high risk of complications. Universal
prescribing would be unsafe in the long term, given the
clear relation between antibiotic prescribing and resist-
ance11 and the fact that, in the short term, antibiotics
can occasionally have severe side effects.12 Not
prescribing antibiotics at all is likely to have even
higher rates of complications.9 13
When to return
Advising patients to return if they are getting worse
may be an acceptable alternative, and one that provides
the prescriber with more (arguably spurious) control.
But evidence suggests this strategy would result in
higher reconsultation rates for the acute illness,3 and it
is not clearly preferable to delayed prescribing with
clear instructions. Nevertheless, doctors should advise
patients clearly about returning for antibiotics and fur-
ther assessment if there are signs of complications
developing in any upper respiratory tract infection,
such as inability to swallow, worsening shortness of
breath, and worsening systemic features such as fever
or vomiting. Reserving antibiotics for patients at higher
risk of complications might be a sensible strategy, but it
depends more on clinical opinion than on evidence:
there are few good prospective clinical studies in upper
respiratory tract infection to confirm who is at risk of
severe or prolonged symptoms or of complications.14
On current evidence, as long as patients have clear
and specific information about when to use antibiotics
and when to return for reassessment, delayed prescrib-
ing of antibiotics for upper respiratory tract infection is
probably as safe or safer than other strategies and is
acceptable to patients.
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The patient safety story
Has been told; now it is time to make practice safer
Investigating and improving patient safety in healthcare is now an international phenomenon. Theestablishment of the National Patient Safety
Agency in the United Kingdom1 and of the Center for
Quality Improvement and Patient Safety in the United
States2 are prime examples of the prominence given to
safety within the wider concept of healthcare quality.
No longer can there be any doubt that the most funda-
mental ethical principle in medicine—first, do no
harm—is being taken seriously by a wide constituency.
The next step is to embed safe practice into everyday
clinical behaviour.
Why is there so much interest in patient safety?
Why now? Data have been available on error rates in
medicine for at least a decade. Although there had
been earlier work in the 1970s, the landmark Harvard
Medical Practice study of hospital inpatients was
published in 1991.3 Additional studies followed from
Australia and other contexts.4 This research points to
an adverse event rate in secondary care close to 10%.
The error rate in primary care is less well studied.
What we know
The catalyst came from the United States. By 1998
some opinion leaders in health care were frustrated by
the lack of attention given to addressing serious quality
challenges. An extensive review of the literature on
quality, conducted by RAND Health, documented
shortcomings in both safety and effectiveness.5 Expert
panels, one convened by the Institute of Medicine and
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another established by the President of the United
States, recommended that improving healthcare
quality should become a national priority.6 7 But
despite the strong, convincing evidence and recom-
mendations from expert panels, the “quality problem”
never made it on to the national agenda.
In another effort to bring the issues to the fore-
front, the Institute of Medicine established its quality of
care in America committee. In late 1999 the
committee’s first report, To Err is Human, was released.8
Unlike previous reports on quality, which had been
directed at elected representatives, healthcare leaders,
and professionals, the key audience for this report was
the lay public. In effect, it was direct marketing to
patients about medical errors. The impact was tangible,
with near saturation coverage in the media for almost
three days. The United Kingdom responded with its
own analysis, An Organisation with a Memory.9
There are many lessons here. Firstly, targeting the
public made the issue visible and widened the debate.
Secondly, and just as important, was the clarity of the
message. Errors are something that everyone can
understand. People are familiar with “accidents” and
efforts to avoid them. There are parallels in air and
road transport; indeed in these services there are insti-
tutions to protect the public. Thirdly, the report
focused primarily on errors of execution—events that
no one intended to happen and where there is wide
agreement that something went wrong.8 This level of
consensus is qualitatively different from discussions
about other quality issues, such as medical effective-
ness, where there is often disagreement about what
constitutes evidence based practice, or the applicability
of the evidence to particular patients and circum-
stances. Fourthly, the report made it clear that more
people die as a result of medical errors than from other
common causes of death including motor vehicle
crashes, breast cancer, and AIDS. The case was
therefore made for giving attention and resources
commensurate with the scale of the problem.
The epidemiology of error
Five years have passed since To Err is Human was
released, and a clearer picture of the epidemiology of
error is emerging. As each new report arrives, there is
a growing realisation that error in medicine is on a dif-
ferent scale from error tolerated elsewhere and has
different consequences from error in other service sec-
tors. Ideas about solutions are also arriving from disci-
plines outside medicine, including systems engineer-
ing, psychology, human factors, and informatics.
It’s becoming clear that providing safe and effective
care requires not only expert clinicians, but also well
designed care processes and organisational supports.
Industrial processes have long since developed the
concept of zero tolerance for error, building quality
into production. To better understand why errors
occur, health care is now taking advantage of tools such
as root cause analysis and failure mode effects analysis,
tools already in use in fields such as aviation. Perhaps
even more important, many countries are investing
significant resources in electronic health record
systems that provide clinicians, and hopefully patients,
with improved access to relevant data and decision
support.When used effectively by care teams these sys-
tems will be a powerful tool for preventing many types
of errors. Equally important are efforts to promote a
culture of safety: a recognition that errors are most
often the result of poorly designed systems, while at the
same time encouraging everyone to identify and learn
from errors.10
As we entered a new millennium, we saw that medi-
cine had arrived at a tipping point.11 The patient safety
story coincided with the long awaited arrival of credible
patient centred health care. Patients had, as never before,
access to credible online information. Clinicians became
interested in the concepts of sharing decisions and com-
municating risk,12 and it became obvious that medical
paternalism was on borrowed time.
A new website
The World Health Organization’s Patient Safety
Alliance is yet another signal of this shift. In the UK not
only has the National Patient Safety Agency been
formed within the NHS,1 a research programme has
also been established and a patient safety initiative sup-
ported by the Health Foundation. As a contribution to
this activity, a new website has also been created. safer-
healthcare (www.saferhealthcare.org.uk) is run by a
partnership of the National Patient Safety Agency, the
BMJ Publishing Group, and the Boston based Institute
for Healthcare Improvement. Its aim is to be a valued
source of peer reviewed tools and information to help
practitioners make changes in their organisations. You
are invited to register, find colleagues with similar
interests, discuss, debate, and take up the offer to write
about your work—in short, to be part of the patient
safety story.
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Vitamin and mineral supplements for preventing
infections in older people
May have a place for some, but improved diet and physical activity will do more good
The number of older people is growing rapidlyworldwide. In England alone the number ofpeople older than 65 has more than doubled
since the 1930s, and one fifth of the population is now
aged 60 or more.1 Ageing, disease, lifestyle, and
environmental factors may all impair in older people
the acquisition of food and its intake, processing, and
metabolism, all leading to poor nutritional status.2
Ageing is also associated with decreases in physical
activity and lean body mass and an increase in body fat.
The accompanying reductions in energy requirements
and intake of food lead to lower intakes of macronutri-
ents and micronutrients.2
Many older people exhibit poor immune responses
and are at a high risk of infection.3 Although the
mechanisms leading to the age related decline in
innate and adaptive immunity are poorly understood,
several studies have shown a beneficial effect on the
immune system of supplementing vitamins A, C, and
E, and zinc and selenium, singly and as multinutrient
supplements.3
Yet most prospective trials have found no beneficial
effects of multivitamin supplements on infection
among healthy older people,4 5 and a recent meta-
analysis of randomised controlled trials found the evi-
dence for multivitamins and mineral supplements on
risk of infections in older people to be weak and
conflicting.6 Nevertheless, Girodon et al reported that
supplementation with trace elements and vitamins
reduced infections in institutionalised older people.7
Last year Meydani et al reported a protective effect of
vitamin E supplementation over one year against
infections of the upper respiratory tract, particularly
the common cold, in elderly residents of nursing
homes.8
Limitations
In this week’s BMJ, Avenell et al report the results of a
pragmatic, randomised, double blind, placebo control-
led trial of daily supplements of multivitamins and
minerals on morbidity from infections in people aged
65 and older (p 324).9 This study found that, in older
people livingathome,daily supplementationwithmulti-
vitamins and multiminerals over one year had no ben-
eficial effects on self reported infections, use of health
services, or quality of life.
This was a robust study overall, and it largely
confirms previous research. Having said that, all
studies have their limitations, and the simplicity of the
assessments in this trial by Avenell et al may have lead
to confounding and measurement biases. For example,
neither the researchers nor participants collected data
on dietary intake or physical activity during the study
period. And, although the trial design included a check
of compliance with the supplements in a random 10%
sample of participants, it did not include outcome data
on biochemical status of vitamin and minerals. Two
other important limitations, which the authors
acknowledge, are the low doses of multivitamins
and minerals used and the relatively healthy study
population.
If trials of low dose supplementation show little or
no benefit, might higher doses be more effective? Per-
haps, but higher doses of such supplements in older
people are not without risks. For instance higher doses
of zinc and vitamin A supplements impair cellular
immunity and the health of bones, respectively, among
older people with vitamin D deficiency.2 10 Further-
more, the results of studies using doses that exceed
recommended daily requirements for micronutrients
cannot be readily translated into dietary guidelines.
Few studies have attempted to modulate immune
status in older people using foods or doses of nutrients
that are realistically achievable through changing
diet.11
Holistic approach to diet
Diets of poor quality and quantity underlie and exacer-
bate many causes of major disease in older people and
society as a whole including hypertension, type 2
diabetes, obesity, heart disease, stroke, cancer, mental ill
health, and infections.12 Evidence is increasing for a
holistic approach to improving diet rather than focus-
ing too closely on the effects of individual nutrients on
risk factors and preventing disease. If combined with
physical activity, which can increase appetite and
enable a diet of marginal nutrient density to become
adequate,12 a better diet can make a substantial impact
on population health, particularly of older people.
Supplements of vitamins and minerals might still
benefit older people with increased risk of infections
and those with evidence of vitamin deficiencies. But we
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